Experimental NeuroTherapeutics Laboratory, Institute for Biological Sciences, National Research Council Canada, 1200 Montreal Road, Bldg M54, Ottawa, Ontario, Canada K1A 0R6.
Biochem Biophys Res Commun. 2010 Oct 22;401(3):435-9. doi: 10.1016/j.bbrc.2010.09.074. Epub 2010 Sep 24.
Brain microglia are resident macrophage-like cells representing the first and main form of active immune response during brain injury. Microglia-mediated inflammatory events in the brain are known to be associated with chronic degenerative diseases such as Multiple Sclerosis, Parkinson's, or Alzheimer's disease. Therefore, identification of mechanisms activating microglia is not only important in the understanding of microglia-mediated brain pathologies, but may also lead to the development of new anti-inflammatory drugs for the treatment of chronic neurodegenerative diseases. Recently, abscisic acid (ABA), a phytohormone regulating important physiological functions in higher plants, has been proposed to activate murine microglial cell line N9 through increased intracellular calcium. In the present study, we determined the response to ABA and its analogues from murine primary microglia and immortalized murine microglial cell line BV-2 and N9 cells. A Fura-2-acetoxymethyl ester (Fura-2AM)-based ratiometric calcium imaging and measurement technique was used to determine the intracellular calcium changes in these cells when treated with (-)-ABA, (+)-ABA, (-)-trans-ABA and (+)-trans-ABA. Both primary microglia and microglial cell lines (BV-2 and N9 cells) showed significant increase in intracellular calcium ([Ca(2+)]i) in response to treatment with ATP and ionomycine. However, ABAs failed to evoke dose- and time-dependent [Ca(2+)]i changes in mouse primary microglia, BV-2 and N9 cells. Together, these surprising findings demonstrate that, contrary to that reported in N9 cells [3], ABAs do not evoke intracellular calcium changes in primary microglia and microglial cell lines. The broad conclusion that ABA evokes [Ca(2+)]i in microglia requires more evidence and further careful examination.
脑小胶质细胞是驻留的巨噬细胞样细胞,代表脑损伤时主动免疫反应的第一和主要形式。众所周知,小胶质细胞介导的脑内炎症事件与多发性硬化症、帕金森病或阿尔茨海默病等慢性退行性疾病有关。因此,鉴定激活小胶质细胞的机制不仅对理解小胶质细胞介导的脑病理学很重要,而且还可能导致开发新的抗炎药物来治疗慢性神经退行性疾病。最近,脱落酸(ABA),一种调节高等植物重要生理功能的植物激素,已被提议通过增加细胞内钙来激活鼠小胶质细胞系 N9。在本研究中,我们测定了 ABA 及其类似物对鼠原代小胶质细胞和永生化鼠小胶质细胞系 BV-2 和 N9 细胞的反应。使用基于 Fura-2-乙氧基甲酯(Fura-2AM)的比率钙成像和测量技术,当用 (-)-ABA、(+)-ABA、(-)-反式-ABA 和 (+)-反式-ABA 处理这些细胞时,测定细胞内钙变化。原代小胶质细胞和小胶质细胞系(BV-2 和 N9 细胞)均显示出对 ATP 和离子霉素处理的细胞内钙([Ca(2+)]i)的显著增加。然而,ABAs 未能引起小鼠原代小胶质细胞、BV-2 和 N9 细胞的剂量和时间依赖性 [Ca(2+)]i 变化。总之,这些令人惊讶的发现表明,与 N9 细胞中报道的相反[3],ABAs 不会引起原代小胶质细胞和小胶质细胞系的细胞内钙变化。ABA 引起 [Ca(2+)]i 在小胶质细胞中的广泛结论需要更多的证据和进一步仔细的检查。